NEUROMUSCULAR

NeurologyLive's Neuromuscular Clinical Focus page focuses on the latest news and research for rare disorders like amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), and myasthenia gravis (MG).

Insight from Peter Marks, MD, PhD

FDA Addresses Zolgensma Gene Therapy Data Manipulation

The agency said the gene therapy should remain on the market while it assesses the situation and does not impact their evaluation of data from the human clinical trials.

Nusinersen Shows Long-Term SMA Success, Positive Data for an Investigational DMD Therapy, Zogenix to Resubmit Fenfluramine NDA

Neurology News Network for the week ending July 6, 2019.

FDA Approves Varibar Thin Liquid for Dysphagia Studies

Dysphagia is a common symptom and complication of neurologic disorders, yet no clear treatment protocol has been identified.

Can Telemedicine Make a Difference in Neurology Subspecialties?

The staff neurologist at Cleveland Clinic’s Mellen Center for MS shared her insight into the use of telemedicine in an outpatient setting across a number of subspecialties in neurology and how it can supplement care going forward.

Mallinckrodt Halts Phase 2b ALS Trial for Repository Corticotropin Injection

The phase 2b trial of the repository corticotropin injection (Acthar Gel) in amyotrophic lateral sclerosis was halted due to data and safety board concerns of the potential risk of pneumonia.

Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness

Spinal Muscular Atrophy: Parting Advice for Clinicians

Optimized Care in the Evolving SMA Treatment Paradigm

Previous Page Next Page

About NeurologyLive's Neuromuscular Clinical Focus page:

The NeurologyLive Neuromuscular Clinical Focus page provides the latest clinical updates about neuromuscular diseases, with articles and videos covering the most up-to-date advancements in the field. Visitors to the clinical focus page will find information on emerging treatment options, as well as updates from the world’s top neurology conferences and annual meetings, including key coverage on rare disorders like ALS, DMD, and MD.

Additionally, articles and video editorial from neurologists and professionals specializing in neuromuscular conditions can be found on this page, offering expert guidance on current management strategies and potential neuromuscular therapy options.